about
Drug points: Acute renal failure induced by topical ketoprofenInternational and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.Comparison of cystatin C, creatinine and creatinine clearance vs. GFR for detection of renal failure in renal transplant patients.A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.Renal biopsy practice in France: results of a nationwide study.[Renal biopsy practice: results of a French study and recommendations].Renal transplantation in patients with sarcoidosis: a French multicenter studyBardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohortSpectrum of mutations in Gitelman syndrome.The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.Pharmacokinetics of habekacin in patients with renal insufficiency.Correction of postkidney transplant anemia reduces progression of allograft nephropathy.Localization of tubular adaptation to renal sodium loss in Gitelman syndrome.Comparing the Bbs10 complete knockout phenotype with a specific renal epithelial knockout one highlights the link between renal defects and systemic inactivation in miceImpaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort studyRuling out nosocomial transmission of Cryptosporidium in a renal transplantation unit: case report.Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study.Impaired platelet P2Y12 inhibition by thienopyridines in chronic kidney disease: mechanisms, clinical relevance and pharmacological options.Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.Intraoperative Pleth Variability Index Is Linked to Delayed Graft Function After Kidney Transplantation.Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.Nephrotoxicity of antitumoral agents.Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.Recent Changes in Chronic Kidney Disease-Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation.Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections.Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype.Acute renal failure and nephrotic syndrome with alpha interferon therapy.ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.High-affinity interaction of long-chain fatty acids with serum albumin in nephrotic syndrome.B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure.
P50
Q28343856-0FE9CF70-D1B2-4A3D-8F74-5A6187655766Q30234696-9C6A5DF6-649C-4CAC-B202-7286CE80B4CCQ33206569-D344DFCD-B533-4C23-9905-6ECDC68A9E60Q33347170-27893842-2F26-4980-B0C7-C2AF48D21163Q33405246-5DE4D65A-ECDA-4941-8C4F-24BC771C510DQ33422371-D796F4FE-D8BF-4B7F-9613-6C2A01BC275CQ33577706-A9059A10-D84D-4334-B92B-D4DA12EEB684Q34198699-1F0ED1A5-936D-4F4E-8D5C-B850DE60E011Q34405427-B5E7F72E-8ECD-4564-B5E3-75FB1DF6741EQ34497248-BBA4C1CC-4C75-4DE5-BBD0-FDCDDEC04190Q34726867-6A23C51B-BADC-4FEC-955F-A8BFB1CF2871Q35220198-3A42B72F-F34F-4CE9-A674-EDD52BE3E116Q35538739-6DA84198-D64E-4153-B5AB-925ED152C6E2Q35715841-86FFA41D-B3C2-4BAA-84C2-F360E03C342DQ35827299-2DAB946F-2A21-4775-AEEB-AB3FE73A2B47Q35951221-9C02A845-DC43-4376-AA99-0F7A7645BD43Q36045746-D2BDF767-B0C2-483A-AA84-D80CCDC929B3Q36092805-3F38827D-8DCE-46D2-9EBE-F81F997BCC16Q36297604-3D02945F-306E-46F2-B2C6-6D4BFB98C545Q37651129-2D862E33-6E91-41BE-A7BE-290C827E2159Q38087944-1BC1E203-6715-47C2-9C83-1AA4EEA1C790Q38183114-02F956CC-176F-4AD3-ABDD-A6DDCB82DE16Q38587538-5FB1F9A2-E644-48A5-B567-227C6D04A2C8Q38619244-5A7ED08F-5145-46B8-8147-62F5C3FFC088Q39016179-5241196B-BC89-4FB1-8EC3-4F4EACAB7801Q39242751-82088039-2E30-4F36-8E0C-6F8451166263Q39420843-D896DF71-C900-4681-A54E-6810AF94C5E4Q39464615-95766F39-E7D1-4C01-BED2-D8EA1FB178D4Q39550390-BE471059-29B2-4130-AA01-6D8EFF11AC46Q39600542-6CBCD655-16F4-4254-AE56-ACFAF0E0C026Q40363938-0748914B-A173-4E1D-94D6-E91263A16107Q40612770-FDA79000-9D51-4845-AF7C-D67B5E0329B2Q40736051-F12F67A0-9E1E-49FB-846A-15B065EEFA1CQ40750400-375B5AA7-73C2-47AC-9557-00C9B381C605Q41347565-C06E3639-224C-4C48-9AAC-1C093A23938DQ41439288-631BC58A-B028-4A84-9C08-65AB35E16A61Q41472979-2915ECB1-8763-497A-AD34-66D711987238Q41654476-8418E645-36BE-4ECC-A8CD-0B5502B0128CQ42371173-F1B88B19-A882-4C89-925B-765D7B4AE42DQ42439232-C8C213D5-81DE-4F2C-BC10-02CB0C82907A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Moulin
@ast
Bruno Moulin
@en
Bruno Moulin
@es
Bruno Moulin
@nl
Bruno Moulin
@sl
type
label
Bruno Moulin
@ast
Bruno Moulin
@en
Bruno Moulin
@es
Bruno Moulin
@nl
Bruno Moulin
@sl
prefLabel
Bruno Moulin
@ast
Bruno Moulin
@en
Bruno Moulin
@es
Bruno Moulin
@nl
Bruno Moulin
@sl
P214
P106
P21
P213
0000 0000 0924 9153
P214
P31
P496
0000-0001-6772-7165
P569
1953-12-15T00:00:00Z
P734
P735
P7859
viaf-17455750